DAPA

Study Information

Status: Active, Recruiting

Study Details

View study details on clinicaltrials.gov.

Locations

San Francisco

Clinical Trial FAQs

Information for patients and study volunteers, including frequently asked questions.

Description

A Multicenter, Randomized, Double-Blind, Parallel Group, Placebo-Controlled Trial to Evaluate the Effect of In-Hospital Initiation of Dapagliflozin on Clinical Outcomes in Patients With Heart Failure With Reduced Ejection Fraction Who Have Been Stabilized During Hospitalization for Acute Heart Failure DAPAgliflozin and Effect on Cardiovascular Events in ACuTe Heart Failure -Thrombolysis in Myocardial Infarction 68 (DAPA ACT HF-TIMI 68)

Location: CPMC (San Francisco)

Please contact: Milena Ferreira ferreiml@sutterhealth.org about study DAPA

Principal Investigator

Michael Pham, MD, MPH

Co-Investigator(s)

Jared Herr, MD, Ranjan Ray, MD, Yu Xie, MD

Related Studies

Interpretable Deep Learning Model for Longitudinal Electronic Health Record and Applications to Heart Failure Prediction

Develop advanced deep learning model to predict early onset heart failure using EHRs, including structured and unstructured data.

Investigators: External PI, Principal Investigator, Xiaowei (Sherry) Yan, PhD, MS

Heart Failure Prevention "2 of 3 Study".

Primary prevention of heart failure among older adults who have no prior heart failure, myocardial infarction, nor advanced renal impairment

Investigators: Craig Ruggles, M.D., Andrew Hudnut, MD, Francisco Prieto, MD

Interagency Registry for Mechanically Assisted Circulatory Support

Investigator: Robert Kincade, M.D., FACS